3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
133
Lung Neoplasms
74
Brain Neoplasms
27
Small Cell Lung Carcinoma
15
Melanoma
13
Breast Neoplasms
12
Neoplasm Metastasis
11
Neoplasms
9
Carcinoma, Renal Cell
7
Adenocarcinoma of Lung
7
Prostatic Neoplasms
6
NSCLC
5
Urinary Bladder Neoplasms
4
Recurrence
3
Liver Neoplasms
3
Kidney Neoplasms
3
Gastrointestinal Neoplasms
3
Carcinoma, Bronchogenic
3
Bronchial Neoplasms
3
Breast Neoplasms, Male
3
Thoracic Neoplasms
2
Sarcoma
2
Respiratory Tract Neoplasms
2
Respiratory Tract Diseases
2
Neoplasms by Site
2
Mesothelioma
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Neuroendocrine
2
Interventions
Carboplatin
18
Pemetrexed
10
Paclitaxel
6
pembrolizumab
5
Nivolumab
5
Cisplatin
5
Gemcitabine
4
osimertinib
3
entinostat
3
camrelizumab
3
atezolizumab
3
Erlotinib Hydrochloride
3
selpercatinib
2
pralsetinib
2
durvalumab
2
apatinib
2
Vinorelbine
2
Surveys and Questionnaires
2
One-Lung Ventilation
2
Ipilimumab
2
Drug Delivery Systems
2
Docetaxel
2
Bronchoscopy
2
Bevacizumab
2
130-nm albumin-bound paclitaxel
2
zipalertinib
1
zimberelimab
1
toripalimab
1
taletrectinib
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Diseases
×
Radiosurgery
×
Thoracic
×
Clear all
NCT02984761
2026-02-19
VALOR
VA Office of Research and Development
Phase NA
Recruiting
670 enrolled